In partnership with

AIHealthTech Insider: Issue # 28

Dive into AI's role in revolutionizing healthcare, from precise stroke diagnosis with CNN-R to affordable screenings by Helfie AI. We'll also explore AI Santa aiding diabetes research, AI in medical education at ChangeMedEd 2025, and Tempus AI's new partnership with Blue Cross Blue Shield for advanced cancer care.

🩺Helfie AI: Revolutionizing Affordable Health Screenings

Helfie AI is transforming healthcare with affordable, AI-powered screenings for illnesses like COVID-19, tuberculosis, and skin conditions. Using a smartphone camera, users can access quick checks for as low as $0.20 per screen. Focusing on respiratory and cardiovascular issues, Helfie encourages early detection and timely doctor visits, reducing preventable deaths.

$200M Funding to Scale Helfie

Founder George Tomeski is raising $200 million to scale Helfie globally by mid-2025. The funds will enhance AI-driven product development, expand marketing, hire talent, and ensure regulatory compliance. Helfie AI aims to lead preventive care with accessible, life-saving technology.

 🎅 AI Santa Chats for Diabetes Research

Dive into the magic of Christmas with the "Ask Santa" program, where kids can have a personal conversation with an AI Santa. For only $5, your child can chat with Santa and contribute to Breakthrough T1D's mission to fund Type 1 diabetes research.

This initiative, created by StoryFile during the COVID-19 era, combines holiday cheer with philanthropy, offering a unique, interactive experience for children while supporting a vital cause.

SPONSORED CONTENT

An entirely new way to present ideas

Gamma’s AI creates beautiful presentations, websites, and more. No design or coding skills required. Try it free today.

🌐 Redefining Medical Education with AI at ChangeMedEd 2025

ChangeMedEd® 2025, hosted by the American Medical Association, is set to revolutionize how future physicians are trained. This national conference will bring over 500 global leaders to explore high-priority themes like AI in medical education, precision education, equity, and health systems science. Featuring interactive workshops, panel discussions, and an exhibit hall, the event offers unparalleled opportunities to reimagine medical education and improve patient outcomes.

🧠AI Revolution in Stroke Diagnosis: Precision Like Never Before

A groundbreaking study published in npj Digital Medicine reveals that CNN-R, an advanced AI-powered deep learning model, outperforms traditional methods and even doctors in diagnosing stroke onset and identifying recoverable brain tissue. By analyzing unenhanced CT scans, CNN-R offers twice the accuracy of the Net Water Uptake (NWU) method, marking a significant leap in stroke care.

Key Features of CNN-R in Stroke Diagnosis

• Enhanced Accuracy: Achieves twice the precision of NWU in estimating stroke onset and reversible tissue damage.

• AI-Driven Analysis: Analyzes the biological state of brain tissue, incorporating factors like blood flow and tissue resilience for personalized predictions.

• Outperforms Doctors: Delivers more reliable predictions of recoverable tissue, improving decision-making in hyperacute stroke treatment.

• Speed and Precision: Facilitates faster, more personalized care by focusing on tissue reversibility rather than just time since stroke onset.

This research highlights how AI tools like CNN-R can transform stroke diagnosis by delivering faster, personalized, and more accurate results.

🚑Tempus AI Joins Blue Cross Network: A Milestone in Cancer Care

Tempus AI, a leader in AI-powered precision medicine, has achieved in-network status with Blue Cross Blue Shield (BCBS) plans across six states, including Illinois, California, and North Carolina. This groundbreaking partnership ensures that Tempus’s advanced cancer-testing products, which use artificial intelligence for comprehensive molecular profiling, are more accessible to patients. By being in-network, the company aims to accelerate the adoption of its tools, empowering doctors to personalize treatment strategies with greater precision.

This collaboration underscores the transformative role of AI in healthcare. Tempus’s molecular profiling tests analyze vast datasets to guide oncologists in making data-driven decisions, ultimately improving patient outcomes. The move not only expands access to cutting-edge cancer care but also sets a precedent for integrating AI technologies into broader healthcare systems for better, smarter medicine.

📧 Engage with Us:

Stay Ahead: AI Healthcare News!

This is just a taste of AI's healthcare revolution. Subscribe for exclusive updates & insights on AI shaping medicine's future!